Significance of levothyroxine treatment on serum lipid in pregnant women with subclinical hypothyroidism
Abstract Background There is no consensus reference range for serum lipid levels during pregnancy. The benefit of levothyroxine (L-T4) on serum lipid levels are unclear among pregnant women with subclinical hypothyroidism (SCH). Objective To determine the recommended reference ranges for serum lipid...
Saved in:
Main Authors: | Yuxi Yang (Author), Huabing Yuan (Author), Xueran Wang (Author), Zheng Zhang (Author), Ruixia Liu (Author), Chenghong Yin (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of levothyroxine among pregnant women with subclinical hypothyroidism in the United Kingdom: A population‐based assessment
by: Ya‐Hui Yu, et al.
Published: (2021) -
Serum levels of nitrite/nitrate, lipid profile, and Fasting Plasma Glucose and their associations in subclinical hypothyroid women before and after a two month treatment by levothyroxine
by: Hashemi Mohammad Mostakhdem, et al.
Published: (2017) -
Dynamics of gut microbiota during pregnancy in women with TPOAb-positive subclinical hypothyroidism: a prospective cohort study
by: Min Wu, et al.
Published: (2022) -
Does it need administer extra-low dose levothyroxine supplementation to infertile women with subclinical hypothyroidism?
by: Wen-Ling Lee, et al.
Published: (2024) -
Correction: Dynamics of gut microbiota during pregnancy in women with TPOAb-positive subclinical hypothyroidism: a prospective cohort study
by: Min Wu, et al.
Published: (2022)